首页 > 最新文献

Indian Journal of Critical Care Medicine最新文献

英文 中文
Utility of Extracellular Nicotinamide Phosphoribosyl Transferase as a Novel Biomarker in Predicting Early Severe Organ Dysfunction and Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study. 细胞外烟酰胺磷酸核糖基转移酶作为预测急性呼吸窘迫综合征早期严重器官功能障碍和死亡率的新生物标志物:一项前瞻性观察研究。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25092
Shwethapriya Rao, Thejesh Srinivas, Vishwas Parampalli, Pratibha Todur, Ashritha A Udupa, Shruthi Rao, Souvik Chaudhuri

Background and aim: Nicotinamide phosphoribosyl transferase (NAMPT) is an upstream cytozyme (cytokine plus enzyme) with unique features, having intracellular NAMPT (iNAMPT) and extracellular NAMPT (eNAMPT) components. Genetic associations and therapeutic inhibition highlight its potential as both a biomarker and therapeutic target. We aimed to study the utility of eNAMPT as a predictor of severe organ dysfunction and its association with mortality in acute respiratory distress syndrome (ARDS).

Patients and methods: This is a single-center, prospective observational study involving 90 patients with ARDS. We noted plasma eNAMPT levels, oxygenation levels, inflammatory markers, lung ultrasound scores, driving pressures, and echocardiography parameters. Severity of organ dysfunction and ICU mortality were the outcomes.

Results: Plasma eNAMPT was found to be a predictor of severe organ dysfunction in ARDS [adjusted OR: 1.343, 95% CI (1.105-1.634), p-value 0.003]. The cut-off eNAMPT level of ≥ 4.38 ng/mL was used to predict early severe organ dysfunction, with an AUC of 0.752, 95% CI (0.647-0.857), p-value < 0.001, sensitivity of 71.4%, and specificity of 79.2%. Plasma eNAMPT was significantly higher in non-survivors [4.53 (4-9.98) ng/mL] as compared to survivors [3.76 (3.40-4.29) ng/mL] (p-value < 0.001). eNAMPT level ≥4.175 ng/mL was associated with higher mortality (hazard ratio: 3.82; 95% CI: 2.010-7.276, p-value < 0.001) and a shorter median survival time [5 days vs. 16 days (Log-rank (Mantel-Cox) p-value < 0.001].

Conclusion: Plasma eNAMPT (≥4.38 ng/mL) predicts early severe organ dysfunction in ARDS patients. It is also associated with mortality and a shorter median survival time.

How to cite this article: Rao S, Srinivas T, Parampalli V, Todur P, Udupa AA, Rao S, et al. Utility of Extracellular Nicotinamide Phosphoribosyl Transferase as a Novel Biomarker in Predicting Early Severe Organ Dysfunction and Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study. Indian J Crit Care Med 2025;29(12):1010-1019.

背景与目的:烟酰胺磷酸核糖基转移酶(NAMPT)是一种具有独特功能的上游细胞酶(细胞因子加酶),具有细胞内NAMPT (iNAMPT)和细胞外NAMPT (eNAMPT)成分。遗传关联和治疗抑制突出了其作为生物标志物和治疗靶点的潜力。我们的目的是研究eNAMPT作为严重器官功能障碍的预测指标及其与急性呼吸窘迫综合征(ARDS)死亡率的关系。患者和方法:这是一项涉及90例ARDS患者的单中心前瞻性观察性研究。我们记录了血浆eNAMPT水平、氧合水平、炎症标志物、肺超声评分、驱动压力和超声心动图参数。结果是器官功能障碍的严重程度和ICU死亡率。结果:血浆eNAMPT被发现是ARDS严重器官功能障碍的预测因子[校正OR: 1.343, 95% CI (1.105-1.634), p值0.003]。采用截断值≥4.38 ng/mL的eNAMPT水平预测早期严重器官功能障碍,AUC为0.752,95% CI (0.647 ~ 0.857), p值< 0.001,敏感性为71.4%,特异性为79.2%。非幸存者血浆eNAMPT [4.53 (4-9.98) ng/mL]显著高于幸存者[3.76 (3.40-4.29)ng/mL] (p值< 0.001)。eNAMPT水平≥4.175 ng/mL与较高的死亡率(风险比:3.82;95% CI: 2.010-7.276, p值< 0.001)和较短的中位生存时间相关[5天vs. 16天(Log-rank (Mantel-Cox) p值< 0.001]。结论:血浆eNAMPT(≥4.38 ng/mL)可预测ARDS患者早期严重器官功能障碍。它还与死亡率和较短的中位生存时间有关。如何引用本文:Rao S, Srinivas T, Parampalli V, Todur P, Udupa AA, Rao S等。细胞外烟酰胺磷酸核糖基转移酶作为预测急性呼吸窘迫综合征早期严重器官功能障碍和死亡率的新生物标志物:一项前瞻性观察研究。中华检验医学杂志,2015;29(12):1010-1019。
{"title":"Utility of Extracellular Nicotinamide Phosphoribosyl Transferase as a Novel Biomarker in Predicting Early Severe Organ Dysfunction and Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study.","authors":"Shwethapriya Rao, Thejesh Srinivas, Vishwas Parampalli, Pratibha Todur, Ashritha A Udupa, Shruthi Rao, Souvik Chaudhuri","doi":"10.5005/jp-journals-10071-25092","DOIUrl":"10.5005/jp-journals-10071-25092","url":null,"abstract":"<p><strong>Background and aim: </strong>Nicotinamide phosphoribosyl transferase (NAMPT) is an upstream cytozyme (cytokine plus enzyme) with unique features, having intracellular NAMPT (iNAMPT) and extracellular NAMPT (eNAMPT) components. Genetic associations and therapeutic inhibition highlight its potential as both a biomarker and therapeutic target. We aimed to study the utility of eNAMPT as a predictor of severe organ dysfunction and its association with mortality in acute respiratory distress syndrome (ARDS).</p><p><strong>Patients and methods: </strong>This is a single-center, prospective observational study involving 90 patients with ARDS. We noted plasma eNAMPT levels, oxygenation levels, inflammatory markers, lung ultrasound scores, driving pressures, and echocardiography parameters. Severity of organ dysfunction and ICU mortality were the outcomes.</p><p><strong>Results: </strong>Plasma eNAMPT was found to be a predictor of severe organ dysfunction in ARDS [adjusted OR: 1.343, 95% CI (1.105-1.634), <i>p</i>-value 0.003]. The cut-off eNAMPT level of ≥ 4.38 ng/mL was used to predict early severe organ dysfunction, with an AUC of 0.752, 95% CI (0.647-0.857), <i>p</i>-value < 0.001, sensitivity of 71.4%, and specificity of 79.2%. Plasma eNAMPT was significantly higher in non-survivors [4.53 (4-9.98) ng/mL] as compared to survivors [3.76 (3.40-4.29) ng/mL] (<i>p</i>-value < 0.001). eNAMPT level ≥4.175 ng/mL was associated with higher mortality (hazard ratio: 3.82; 95% CI: 2.010-7.276, <i>p</i>-value < 0.001) and a shorter median survival time [5 days vs. 16 days (Log-rank (Mantel-Cox) <i>p</i>-value < 0.001].</p><p><strong>Conclusion: </strong>Plasma eNAMPT (≥4.38 ng/mL) predicts early severe organ dysfunction in ARDS patients. It is also associated with mortality and a shorter median survival time.</p><p><strong>How to cite this article: </strong>Rao S, Srinivas T, Parampalli V, Todur P, Udupa AA, Rao S, <i>et al.</i> Utility of Extracellular Nicotinamide Phosphoribosyl Transferase as a Novel Biomarker in Predicting Early Severe Organ Dysfunction and Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study. Indian J Crit Care Med 2025;29(12):1010-1019.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1010-1019"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: From Narrative to Navigation: A Translational Roadmap for AI-enabled Early Sepsis Prediction-Comment on Shanmugam et al. 作者回应:从叙述到导航:ai支持的早期败血症预测的翻译路线图-评论Shanmugam等人。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25113
Hemalatha Shanmugam, Lavanya Airen, Saumya Rawat

How to cite this article: Shanmugam H, Airen L, Rawat S. Author Response: From Narrative to Navigation: A Translational Roadmap for AI-enabled Early Sepsis Prediction-Comment on Shanmugam et al. Indian J Crit Care Med 2025;29(12):1052-1053.

本文引用方式:Shanmugam H, Airen L, Rawat s作者回复:从叙述到导航:ai支持的早期败血症预测的翻译路线图-评论Shanmugam等人。中华检验医学杂志;2015;29(12):1052-1053。
{"title":"Author Response: From Narrative to Navigation: A Translational Roadmap for AI-enabled Early Sepsis Prediction-Comment on Shanmugam et al.","authors":"Hemalatha Shanmugam, Lavanya Airen, Saumya Rawat","doi":"10.5005/jp-journals-10071-25113","DOIUrl":"10.5005/jp-journals-10071-25113","url":null,"abstract":"<p><p><b>How to cite this article:</b> Shanmugam H, Airen L, Rawat S. Author Response: From Narrative to Navigation: A Translational Roadmap for AI-enabled Early Sepsis Prediction-Comment on Shanmugam et al. Indian J Crit Care Med 2025;29(12):1052-1053.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1052-1053"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776880/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Sci-Hub Ban in India: When Copyright Collides with Clinical Reality. 印度的科学中心禁令:当版权与临床现实发生冲突时。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25102
Tanmoy Ghatak, Utsav A Mani

How to cite this article: Ghatak T, Mani UA. The Sci-Hub Ban in India: When Copyright Collides with Clinical Reality. Indian J Crit Care Med 2025;29(12):986-987.

如何引用这篇文章:Ghatak T, Mani UA。印度的科学中心禁令:当版权与临床现实发生冲突时。中华检验医学杂志;2015;29(12):986-987。
{"title":"The Sci-Hub Ban in India: When Copyright Collides with Clinical Reality.","authors":"Tanmoy Ghatak, Utsav A Mani","doi":"10.5005/jp-journals-10071-25102","DOIUrl":"10.5005/jp-journals-10071-25102","url":null,"abstract":"<p><p><b>How to cite this article:</b> Ghatak T, Mani UA. The Sci-Hub Ban in India: When Copyright Collides with Clinical Reality. Indian J Crit Care Med 2025;29(12):986-987.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"986-987"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of Circulatory Markers of NETosis with COVID-19 Severity: A Prospective Cohort Study. NETosis循环标志物与COVID-19严重程度的关系:一项前瞻性队列研究
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25103
Abhyuday Kumar, Neeraj Kumar, Ayan Banerjee, Ajeet Kumar, Amarjeet Kumar, Chandni Sinha

Background: NETosis is a unique form of cell death leading to the formation of neutrophil extracellular traps (NETs), which may be responsible for many of the serious complications of COVID-19, such as acute respiratory distress syndrome (ARDS), cytokine storm, thromboembolic complications, acute organ dysfunction, and multiorgan failure.

Aims: The aim was to assess the relationship between markers of NETosis [citrullinated histones (Cit-H3), myeloperoxidase (MPO), and elastase] and COVID-19, as well as its severity.

Patients and methods: Ninety-nine hospitalized adult patients aged 18 years or older with COVID-19 and 30 controls were prospectively enrolled. Serum levels of Cit-H3, MPO, and elastase were measured at the time of admission, and their levels were compared between the clinical categories of COVID-19 (non-severe, severe, and critical). The correlation between markers of NETosis and the PO2/FiO2 ratio was also determined.

Results: Among the NETs markers, Cit-H3 and elastase levels significantly increased in the COVID-19 patients compared to the control. In the comparison of COVID-19 categories, only Cit-H3 significantly increased in severe categories compared to the non-severe group. Citrullinated histones showed fair diagnostic ability for the prediction of the severity, with a sensitivity and specificity of approximately 74 and 64%, respectively, at a cut-off of 34 ng/mL. Elastase was found to have a weak negative correlation, while Cit-H3 had a moderate negative correlation with the PO2/FiO2 ratio.

Conclusions: Citrullinated histones, along with C-reactive protein (CRP), are independently associated with COVID-19 severity. These findings support the relevance of NETosis-related biomarkers in disease progression and may inform future research on targeted monitoring strategies.

Clinical trial registration no: Clinical trial registry of India (CTRI/2020/10/028488).

How to cite this article: Kumar A, Kumar N, Banerjee A, Kumar A, Kumar A, Sinha C. Relationship of Circulatory Markers of NETosis with COVID-19 Severity: A Prospective Cohort Study. Indian J Crit Care Med 2025;29(12):1032-1039.

背景:NETosis是一种独特的细胞死亡形式,导致中性粒细胞胞外陷阱(NETs)的形成,这可能是导致COVID-19许多严重并发症的原因,如急性呼吸窘迫综合征(ARDS)、细胞因子风暴、血栓栓塞并发症、急性器官功能障碍和多器官衰竭。目的:目的是评估NETosis标记物[瓜氨酸化组蛋白(Cit-H3)、髓过氧化物酶(MPO)和弹性酶]与COVID-19及其严重程度之间的关系。患者和方法:前瞻性纳入99名18岁及以上住院的成年COVID-19患者和30名对照组。入院时测定血清Cit-H3、MPO和弹性蛋白酶水平,并比较其在COVID-19临床类别(非严重、严重和危重)之间的水平。NETosis标记物与PO2/FiO2比值的相关性也被确定。结果:在NETs标志物中,COVID-19患者的Cit-H3和弹性酶水平较对照组显著升高。在COVID-19类别比较中,只有重症组的Cit-H3较非重症组显著升高。瓜氨酸化组蛋白在预测严重程度方面表现出相当的诊断能力,在34 ng/mL的临界值下,敏感性和特异性分别约为74%和64%。发现Elastase与PO2/FiO2呈弱负相关,Cit-H3与PO2/FiO2呈中度负相关。结论:瓜氨酸化组蛋白和c反应蛋白(CRP)与COVID-19严重程度独立相关。这些发现支持netosis相关生物标志物与疾病进展的相关性,并可能为未来的针对性监测策略研究提供信息。临床试验注册号:印度临床试验注册中心(CTRI/2020/10/028488)。Kumar A, Kumar N, Banerjee A, Kumar A, Kumar A, Sinha C. NETosis循环标志物与COVID-19严重程度关系的前瞻性队列研究。中华检验医学杂志;2015;29(12):1032-1039。
{"title":"Relationship of Circulatory Markers of NETosis with COVID-19 Severity: A Prospective Cohort Study.","authors":"Abhyuday Kumar, Neeraj Kumar, Ayan Banerjee, Ajeet Kumar, Amarjeet Kumar, Chandni Sinha","doi":"10.5005/jp-journals-10071-25103","DOIUrl":"10.5005/jp-journals-10071-25103","url":null,"abstract":"<p><strong>Background: </strong>NETosis is a unique form of cell death leading to the formation of neutrophil extracellular traps (NETs), which may be responsible for many of the serious complications of COVID-19, such as acute respiratory distress syndrome (ARDS), cytokine storm, thromboembolic complications, acute organ dysfunction, and multiorgan failure.</p><p><strong>Aims: </strong>The aim was to assess the relationship between markers of NETosis [citrullinated histones (Cit-H3), myeloperoxidase (MPO), and elastase] and COVID-19, as well as its severity.</p><p><strong>Patients and methods: </strong>Ninety-nine hospitalized adult patients aged 18 years or older with COVID-19 and 30 controls were prospectively enrolled. Serum levels of Cit-H3, MPO, and elastase were measured at the time of admission, and their levels were compared between the clinical categories of COVID-19 (non-severe, severe, and critical). The correlation between markers of NETosis and the PO<sub>2</sub>/FiO<sub>2</sub> ratio was also determined.</p><p><strong>Results: </strong>Among the NETs markers, Cit-H3 and elastase levels significantly increased in the COVID-19 patients compared to the control. In the comparison of COVID-19 categories, only Cit-H3 significantly increased in severe categories compared to the non-severe group. Citrullinated histones showed fair diagnostic ability for the prediction of the severity, with a sensitivity and specificity of approximately 74 and 64%, respectively, at a cut-off of 34 ng/mL. Elastase was found to have a weak negative correlation, while Cit-H3 had a moderate negative correlation with the PO<sub>2</sub>/FiO<sub>2</sub> ratio.</p><p><strong>Conclusions: </strong>Citrullinated histones, along with C-reactive protein (CRP), are independently associated with COVID-19 severity. These findings support the relevance of NETosis-related biomarkers in disease progression and may inform future research on targeted monitoring strategies.</p><p><strong>Clinical trial registration no: </strong>Clinical trial registry of India (CTRI/2020/10/028488).</p><p><strong>How to cite this article: </strong>Kumar A, Kumar N, Banerjee A, Kumar A, Kumar A, Sinha C. Relationship of Circulatory Markers of NETosis with COVID-19 Severity: A Prospective Cohort Study. Indian J Crit Care Med 2025;29(12):1032-1039.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1032-1039"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnose Pediatric Delirium Preferentially by Psychiatric Examination, as CAPD Has Low Specificity. 诊断小儿谵妄优先通过精神病学检查,因为CAPD的特异性较低。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25088
Carla A Scorza, Fulvio A Scorza, Josef Finsterer

How to cite this article: Scorza CA, Scorza FA, Finsterer J. Diagnose Pediatric Delirium Preferentially by Psychiatric Examination, as CAPD Has Low Specificity. Indian J Crit Care Med 2025;29(12):1061-1062.

Scorza CA, Scorza FA, Finsterer J.诊断小儿谵妄优先通过精神病学检查,因为CAPD具有低特异性。中华检验医学杂志;2015;29(12):1061-1062。
{"title":"Diagnose Pediatric Delirium Preferentially by Psychiatric Examination, as CAPD Has Low Specificity.","authors":"Carla A Scorza, Fulvio A Scorza, Josef Finsterer","doi":"10.5005/jp-journals-10071-25088","DOIUrl":"10.5005/jp-journals-10071-25088","url":null,"abstract":"<p><p><b>How to cite this article:</b> Scorza CA, Scorza FA, Finsterer J. Diagnose Pediatric Delirium Preferentially by Psychiatric Examination, as CAPD Has Low Specificity. Indian J Crit Care Med 2025;29(12):1061-1062.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1061-1062"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-care, Point-of-concern? A Commentary on What Ails Point-of-care Ultrasound Education. 现阶段,Point-of-concern ?关于什么困扰着护理点超声教育的评论。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25104
Arvind Rajamani, Anthony McLean, Kishore Pichamuthu, Stephen Huang

Point‑of‑care ultrasound (PoCUS) has transformed bedside diagnostics in critical care, yet its educational framework remains fragmented. Despite decades of use, training often relies on short workshops or ad hoc mentorship, leaving many trainees with suboptimal image-acquisition skills and/or interpretive competence. This commentary highlights barriers to effective PoCUS education, illustrated through clinical cases where misinterpretation posed significant risks. We identify systemic challenges including inconsistent curricula, poorly defined competencies, reliance on arbitrary scan numbers, and limited supervision. Accreditation processes remain variable, with guidelines offering aspirational statements but little implementation detail. Medicolegal concerns further underscore the need for structured training. We propose a way forward through longitudinal, competency‑based programs anchored in educational milestones, validated assessment tools, and quality assurance mechanisms. Global collaboration and standardized frameworks are essential to harmonize training and ensure safe practice. Addressing these gaps will strengthen PoCUS education and safeguard patient outcomes.

How to cite this article: Rajamani A, McLean A, Pichamuthu K, Huang S. Point-of-care, Point-of-concern? A Commentary on What Ails Point-of-care Ultrasound Education. Indian J Crit Care Med 2025;29(12):983-985.

护理点超声(PoCUS)已经改变了重症监护的床边诊断,但其教育框架仍然分散。尽管使用了几十年,但培训往往依赖于短期讲习班或特别指导,使许多受训者的图像获取技能和/或解释能力不佳。这篇评论强调了有效PoCUS教育的障碍,通过临床案例说明,误解造成了重大风险。我们发现了系统性的挑战,包括不一致的课程、不明确的能力定义、对任意扫描数字的依赖以及有限的监督。认证过程仍然多变,指导方针提供了有抱负的声明,但很少有实施细节。医学法律方面的关切进一步强调了有组织培训的必要性。我们建议通过纵向的、基于能力的项目,以教育里程碑、有效的评估工具和质量保证机制为基础,向前发展。全球协作和标准化框架对于协调培训和确保安全操作至关重要。解决这些差距将加强PoCUS教育并保障患者的预后。Rajamani A, McLean A, Pichamuthu K, Huang S. care - Point-of-concern?关于什么困扰着护理点超声教育的评论。中华检验医学杂志;2009;29(12):983-985。
{"title":"Point-of-care, Point-of-concern? A Commentary on What Ails Point-of-care Ultrasound Education.","authors":"Arvind Rajamani, Anthony McLean, Kishore Pichamuthu, Stephen Huang","doi":"10.5005/jp-journals-10071-25104","DOIUrl":"10.5005/jp-journals-10071-25104","url":null,"abstract":"<p><p>Point‑of‑care ultrasound (PoCUS) has transformed bedside diagnostics in critical care, yet its educational framework remains fragmented. Despite decades of use, training often relies on short workshops or ad hoc mentorship, leaving many trainees with suboptimal image-acquisition skills and/or interpretive competence. This commentary highlights barriers to effective PoCUS education, illustrated through clinical cases where misinterpretation posed significant risks. We identify systemic challenges including inconsistent curricula, poorly defined competencies, reliance on arbitrary scan numbers, and limited supervision. Accreditation processes remain variable, with guidelines offering aspirational statements but little implementation detail. Medicolegal concerns further underscore the need for structured training. We propose a way forward through longitudinal, competency‑based programs anchored in educational milestones, validated assessment tools, and quality assurance mechanisms. Global collaboration and standardized frameworks are essential to harmonize training and ensure safe practice. Addressing these gaps will strengthen PoCUS education and safeguard patient outcomes.</p><p><strong>How to cite this article: </strong>Rajamani A, McLean A, Pichamuthu K, Huang S. Point-of-care, Point-of-concern? A Commentary on What Ails Point-of-care Ultrasound Education. Indian J Crit Care Med 2025;29(12):983-985.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"983-985"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. 时机问题:早期抗利尿激素治疗感染性休克的谨慎和机会。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25108
Habib Md R Karim, Ankur Khandelwal, Bheemas Atlapure, Azeez Aspari

How to cite this article: Karim HMR, Khandelwal A, Atlapure B, Aspari A. Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. Indian J Crit Care Med 2025;29(12):1058.

本文作者:Karim HMR, Khandelwal A, Atlapure B, Aspari A。时机问题:早期抗利尿激素治疗感染性休克的谨慎和机会。中华检验医学杂志;2015;29(12):1058。
{"title":"Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock.","authors":"Habib Md R Karim, Ankur Khandelwal, Bheemas Atlapure, Azeez Aspari","doi":"10.5005/jp-journals-10071-25108","DOIUrl":"10.5005/jp-journals-10071-25108","url":null,"abstract":"<p><p><b>How to cite this article:</b> Karim HMR, Khandelwal A, Atlapure B, Aspari A. Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. Indian J Crit Care Med 2025;29(12):1058.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1058"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung Ultrasound in the ICU: Strengths, Limitations, and the Continued Role of Computed Tomography. 肺超声在ICU:优势,局限性和计算机断层扫描的持续作用。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25106
Kundan N Mehta, Drashti M Otiya

How to cite this article: Mehta KN, Otiya DM. Lung Ultrasound in the ICU: Strengths, Limitations, and the Continued Role of Computed Tomography. Indian J Crit Care Med 2025;29(12):1054-1055.

本文摘自:Mehta KN, Otiya DM.《ICU肺部超声:优势、局限性和计算机断层扫描的持续作用》。中华检验医学杂志;2015;29(12):1054-1055。
{"title":"Lung Ultrasound in the ICU: Strengths, Limitations, and the Continued Role of Computed Tomography.","authors":"Kundan N Mehta, Drashti M Otiya","doi":"10.5005/jp-journals-10071-25106","DOIUrl":"10.5005/jp-journals-10071-25106","url":null,"abstract":"<p><p><b>How to cite this article:</b> Mehta KN, Otiya DM. Lung Ultrasound in the ICU: Strengths, Limitations, and the Continued Role of Computed Tomography. Indian J Crit Care Med 2025;29(12):1054-1055.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1054-1055"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Lung Ultrasound in the Intensive Care Unit: Strengths, Limitations, and the Continued Role of Computed Tomography. 作者回应:肺部超声在重症监护病房:优势,局限性,和计算机断层扫描的持续作用。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25109
Ashraf S Al Tayar, Hosni A Salem, Prashant Nasa

How to cite this article: Al Tayar AS, Salem HA, Nasa P. Author Response: Lung Ultrasound in the Intensive Care Unit: Strengths, Limitations, and the Continued Role of Computed Tomography. Indian J Crit Care Med 2025;29(12):1056-1057.

本文摘自:Al Tayar AS, Salem HA, Nasa P.作者回复:重症监护病房的肺部超声:计算机断层扫描的优势、局限性和继续作用。中华检验医学杂志;2015;29(12):1056-1057。
{"title":"Author Response: Lung Ultrasound in the Intensive Care Unit: Strengths, Limitations, and the Continued Role of Computed Tomography.","authors":"Ashraf S Al Tayar, Hosni A Salem, Prashant Nasa","doi":"10.5005/jp-journals-10071-25109","DOIUrl":"10.5005/jp-journals-10071-25109","url":null,"abstract":"<p><p><b>How to cite this article:</b> Al Tayar AS, Salem HA, Nasa P. Author Response: Lung Ultrasound in the Intensive Care Unit: Strengths, Limitations, and the Continued Role of Computed Tomography. Indian J Crit Care Med 2025;29(12):1056-1057.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1056-1057"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-reactive Protein/Albumin Ratio as a Predictive Inflammatory Marker for Postoperative Systemic Inflammatory Response Syndrome and/or Sepsis in Polytraumatized Patients in ICU. c反应蛋白/白蛋白比率作为ICU多创伤患者术后全身炎症反应综合征和/或脓毒症的预测炎症标志物
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-01 Epub Date: 2025-12-19 DOI: 10.5005/jp-journals-10071-25091
Ahmed S Salem, Mohamed A Zaghloul, Alfred M Boctor, Mohamed Maher Abd Elfattah, Oliver M Shehata

Background and aims: Trauma continues to represent a major global contributor to morbidity and mortality, with individuals sustaining polytrauma particularly vulnerable to developing systemic inflammatory response syndrome (SIRS) and sepsis. This study aims to evaluate the C-reactive protein (CRP) to albumin ratio (CAR) in predicting the postoperative SIRS and sepsis occurrence among polytrauma cases admitted to intensive care units (ICUs).

Patients and methods: This prospective observational study involved 100 polytrauma cases admitted to Ain Shams University Hospital ICUs. C-reactive protein and albumin levels were measured upon ICU admission and on postoperative days 1, 3, and 5. The CAR was calculated, and its association with SIRS and sepsis was assessed.

Results: Systemic inflammatory response syndrome developed in 35% and sepsis in 28% of patients. C-reactive protein/albumin ratio (CAR) was significantly higher in SIRS-positive patients at Day-1 (median 9.7 vs 8.0, p < 0.001), Day-3 (17.5 vs 11.9, p < 0.001), and Day-5 (28.9 vs 13.8, p < 0.001). C-reactive protein/albumin ratio (CAR) also differentiated sepsis-positive patients at Day-3 (17.7 vs 12.1, p < 0.001) and Day-5 (29.0 vs 14.0, p < 0.001). Receiver-operating characteristic (ROC) analysis showed that CAR at Day-5 had an area under the curve (AUC) of 0.989 for SIRS (sensitivity: 91.4%, specificity: 98.5%) and 0.934 for sepsis (sensitivity: 89.3%, specificity: 88.9%).

Conclusion: Progressive elevation of CAR is a reliable early predictor of postoperative SIRS and sepsis in polytrauma patients, peaking on Day-5.

Clinical significance: Early detection of postoperative sepsis in polytrauma patients by a simple, inexpensive screening tool allows risk stratification and timely intervention of this high-risk group, improving clinical outcomes.

How to cite this article: Salem AS, Zaghloul MA, Boctor AM, Abd Elfattah MM, Shehata OM. C-reactive Protein/Albumin Ratio as a Predictive Inflammatory Marker for Postoperative Systemic Inflammatory Response Syndrome and/or Sepsis in Polytraumatized Patients in ICU. Indian J Crit Care Med 2025;29(12):1002-1009.

背景和目的:创伤仍然是全球发病率和死亡率的主要因素,患有多重创伤的个体特别容易发生全身性炎症反应综合征(SIRS)和败血症。本研究旨在评估c反应蛋白(CRP)与白蛋白比(CAR)在预测重症监护病房(icu)多发创伤患者术后SIRS和脓毒症发生中的作用。患者和方法:本前瞻性观察研究纳入了艾因沙姆斯大学医院icu收治的100例多发创伤病例。c反应蛋白和白蛋白水平在ICU入院时和术后第1、3、5天测定。计算CAR,并评估其与SIRS和脓毒症的相关性。结果:35%的患者出现全身性炎症反应综合征,28%的患者出现败血症。sirs阳性患者在第1天(中位数9.7 vs 8.0, p < 0.001)、第3天(17.5 vs 11.9, p < 0.001)和第5天(28.9 vs 13.8, p < 0.001)的c反应蛋白/白蛋白比率(CAR)显著升高。c反应蛋白/白蛋白比值(CAR)也能在第3天(17.7 vs 12.1, p < 0.001)和第5天(29.0 vs 14.0, p < 0.001)区分败血症阳性患者。受试者工作特征(ROC)分析显示,第5天CAR对SIRS的曲线下面积(AUC)为0.989(敏感性:91.4%,特异性:98.5%),对脓毒症的CAR为0.934(敏感性:89.3%,特异性:88.9%)。结论:CAR进行性升高是多发创伤患者术后SIRS和脓毒症的可靠早期预测指标,在第5天达到峰值。临床意义:通过一种简单、廉价的筛查工具,早期发现多发创伤患者术后脓毒症,可以对该高危人群进行风险分层,及时干预,改善临床预后。如何引用本文:Salem AS, Zaghloul MA, botor AM, Abd Elfattah MM, Shehata OM。c反应蛋白/白蛋白比率作为ICU多创伤患者术后全身炎症反应综合征和/或脓毒症的预测炎症标志物中华检验医学杂志;2015;29(12):1002-1009。
{"title":"C-reactive Protein/Albumin Ratio as a Predictive Inflammatory Marker for Postoperative Systemic Inflammatory Response Syndrome and/or Sepsis in Polytraumatized Patients in ICU.","authors":"Ahmed S Salem, Mohamed A Zaghloul, Alfred M Boctor, Mohamed Maher Abd Elfattah, Oliver M Shehata","doi":"10.5005/jp-journals-10071-25091","DOIUrl":"10.5005/jp-journals-10071-25091","url":null,"abstract":"<p><strong>Background and aims: </strong>Trauma continues to represent a major global contributor to morbidity and mortality, with individuals sustaining polytrauma particularly vulnerable to developing systemic inflammatory response syndrome (SIRS) and sepsis. This study aims to evaluate the C-reactive protein (CRP) to albumin ratio (CAR) in predicting the postoperative SIRS and sepsis occurrence among polytrauma cases admitted to intensive care units (ICUs).</p><p><strong>Patients and methods: </strong>This prospective observational study involved 100 polytrauma cases admitted to Ain Shams University Hospital ICUs. C-reactive protein and albumin levels were measured upon ICU admission and on postoperative days 1, 3, and 5. The CAR was calculated, and its association with SIRS and sepsis was assessed.</p><p><strong>Results: </strong>Systemic inflammatory response syndrome developed in 35% and sepsis in 28% of patients. C-reactive protein/albumin ratio (CAR) was significantly higher in SIRS-positive patients at Day-1 (median 9.7 vs 8.0, <i>p</i> < 0.001), Day-3 (17.5 vs 11.9, <i>p</i> < 0.001), and Day-5 (28.9 vs 13.8, <i>p</i> < 0.001). C-reactive protein/albumin ratio (CAR) also differentiated sepsis-positive patients at Day-3 (17.7 vs 12.1, <i>p</i> < 0.001) and Day-5 (29.0 vs 14.0, <i>p</i> < 0.001). Receiver-operating characteristic (ROC) analysis showed that CAR at Day-5 had an area under the curve (AUC) of 0.989 for SIRS (sensitivity: 91.4%, specificity: 98.5%) and 0.934 for sepsis (sensitivity: 89.3%, specificity: 88.9%).</p><p><strong>Conclusion: </strong>Progressive elevation of CAR is a reliable early predictor of postoperative SIRS and sepsis in polytrauma patients, peaking on Day-5.</p><p><strong>Clinical significance: </strong>Early detection of postoperative sepsis in polytrauma patients by a simple, inexpensive screening tool allows risk stratification and timely intervention of this high-risk group, improving clinical outcomes.</p><p><strong>How to cite this article: </strong>Salem AS, Zaghloul MA, Boctor AM, Abd Elfattah MM, Shehata OM. C-reactive Protein/Albumin Ratio as a Predictive Inflammatory Marker for Postoperative Systemic Inflammatory Response Syndrome and/or Sepsis in Polytraumatized Patients in ICU. Indian J Crit Care Med 2025;29(12):1002-1009.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 12","pages":"1002-1009"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12776848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1